Page last updated: 2024-09-05

sb 203580 and jte 013

sb 203580 has been researched along with jte 013 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(jte 013)
Trials
(jte 013)
Recent Studies (post-2010) (jte 013)
3,48941,13784060

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)jte 013 (IC50)
Sphingosine 1-phosphate receptor 2Homo sapiens (human)0.0401
Sphingosine 1-phosphate receptor 2Rattus norvegicus (Norway rat)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, H; Huang, J; Huang, K; Lan, T; Liu, P; Liu, W; Peng, J; Shen, X; Xie, X1

Other Studies

1 other study(ies) available for sb 203580 and jte 013

ArticleYear
S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition.
    Experimental cell research, 2012, May-01, Volume: 318, Issue:8

    Topics: Animals; Diabetic Nephropathies; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Flavonoids; Glucose; Hyperglycemia; Imidazoles; Kidney; Lysophospholipids; MAP Kinase Signaling System; Mesangial Cells; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sphingosine; Sphingosine-1-Phosphate Receptors

2012